Priced at a premium to peer multiples and intrinsic cash flows, demanding strong execution to justify current levels.
Moderate quality score of 55/100, reflecting stable operating margins and manageable leverage.
Wall Street forecasts a balanced outlook with consensus price targets near the current price.
Verdict: Average quality business weighed down by significant solvency concerns.
Wall Street is broadly bullish, projecting solid upside alongside robust expected earnings growth. This outlook is strongly supported by highly attractive capital returns, anchored by a strong dividend yield, though free cash flow coverage appears tight.
OCSL demonstrates adequate business quality with stable profitability. However, the balance sheet carries elevated leverage, requiring careful monitoring of debt servicing capabilities.
The company maintains stable top-line performance however, earnings have severely contracted over the same period. This growth is supported by elite operational efficiency, sustaining an impressive 45.2% operating margin.
| Financial Metric | Trend (12Q) | Latest Qtr | 1Y Growth | 3Y CAGR | 5Y CAGR | 10Y CAGR |
|---|---|---|---|---|---|---|
| Revenue | $56.8M | +60.9% | — | — | +13.3% | |
| EBITDA | $7.0M | — | +66.3% | — | — | |
| Net Income | -$18.9M | -41.4% | +5.1% | — | +8.2% | |
| EPS (Diluted) | $-0.21 | -45.8% | -6.7% | -14.0% | +2.7% | |
| Free Cash Flow | -$4.8M | +646.5% | +85.3% | — | — |
| Metric | TTM | 3Y Avg | 5Y Avg | 10Y Avg |
|---|---|---|---|---|
| Gross Margin | 81.2% | 57.0% | 61.1% | 25.5% |
| Operating Margin | 45.2% | 43.9% | 51.3% | -2.2% |
| Net Margin | 17.4% | 30.6% | 42.2% | -6.7% |
| FCF Margin | 4.4% | 51.4% | 19.5% | 122.8% |
| Quarter | EPS Est. | EPS Act. | Surprise | EPS | Rev |
|---|---|---|---|---|---|
| Q2'26Latest | $0.36 | $0.38 | +5.6% | ||
| Q1'26 | $0.38 | $0.41 | +7.9% | ||
| Q4'25 | $0.39 | $0.40 | +3.6% | ||
| Q3'25 | $0.45 | $0.37 | -17.8% | ||
| Q2'25 | $0.51 | $0.45 | -11.8% | ||
| Q1'25 | $0.54 | $0.54 | +0.0% | ||
| Q4'24 | $0.56 | $0.55 | -1.8% | ||
| Q3'24 | $0.57 | $0.55 | -3.5% |
Total return is -4.8% (1Y), lagging the benchmark by -29.8%
| Period | Total Return | vs S&P 500 (Alpha) | Dividend Contribution |
|---|---|---|---|
| YTD | -3.1% | -12.4% | — |
| 1Y | -4.8% | -29.8% | +11.2% |
| 3YCAGR | -3.2% | -22.8% | +30.2% |
| 5YCAGR | +2.0% | -11.0% | +51.8% |
| 10YCAGR | +6.9% | -6.7% | — |
The S&P 500 is at 31.3x trailing P/E — Expensive relative to historical averages.
Quick answers to common questions about Oaktree Specialty Lending Corporation (OCSL) valuation, health, and returns.
Oaktree Specialty Lending Corporation is estimated to be overvalued under our discounted cash flow framework. relative multiples indicate the stock is Expensive versus peers compared to industry peers. overvalued (implying -32.4% downside from DCF intrinsic value of $7.83)
Oaktree Specialty Lending Corporation has multiple valuation anchors: DCF Intrinsic Value: $7.83 | Peer Relative Fair Value: $4.25 | Wall Street Analyst Target: $12.50 (implying +7.9% upside). A convergence of these signals offers higher conviction.
Oaktree Specialty Lending Corporation displays fair financial health with a composite quality score of 55/100, supported by a Piotroski F-Score of 7/9, Return on Invested Capital (ROIC) of 3.7%.
Oaktree Specialty Lending Corporation pays a 14.9% dividend yield, covered by a 437% payout ratio with 0 years of growth, supplemented by a 1.0% buyback yield.
Oaktree Specialty Lending Corporation's current growth trajectory is Accelerating. The company achieved +60.9% 1Y revenue growth and -45.8% 1Y EPS growth, compared to its 3Y revenue CAGR of N/A.
Wall Street consensus is Hold based on 12 analysts, beating EPS expectations in 25% of recent quarters with a 3-quarter streak. The consensus price target represents a +7.9% change from current levels.
Investment risks for Oaktree Specialty Lending Corporation include: -26.6% 1-year max drawdown, stretched payout ratio. Volatility risk is characterized by a beta of 0.58x.
No. These computations are purely quantitative model outputs for informational purposes. They do not account for qualitative management shifts or macro events. Always consult a licensed RIA before buying or selling shares.
Disclaimer: This page is for informational purposes only and does not constitute financial advice. All valuation models, scores, and target estimates are automated computations under stated assumptions and should not be relied upon as the sole basis for any investment decision.